November 2021

NEUROSCIENCES

ADUCANUMAB: WHAT NEUROLOGISTS SHOULD KNOW

Featuring: Ian M. Grant, MD

Ian M. Grant, MD, assistant professor of Neurology at Northwestern Medicine, discusses aducanumab (Aduhelm), which was approved by the FDA on June 7 for use in Alzheimer’s disease. He talks about its effectiveness and clinical impact, indication, and administration and describes important considerations for neurologists and their patients.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. 

You May Also Like